Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

By G. Cheema, V. Roschke, D. Hilbert, W. Stohl. Arthritis & Rheumatism, 2001

853 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. (2002, background): “Previous studies have shown that about 20–25% of patients with SLE or RA have elevated levels of BAFF in their blood (26, 27).”
BAFF: A fundamental survival factor for B cells (2002, background): “gov/htbin-post/Omim/dispmim?270150">Sjogren's syndrome — disorders that primarily affect the kidneys, joints and salivary/lacrymal glands, respectively — an association was found between elevated levels of BAFF in the blood and the severity of diseas”
The risk of lymphoma development in autoimmune diseases: a meta-analysis. (2005, result): “In this regard, patients with pSS with an increased risk of NHL are characterized by splenomegaly, lymphadenopathy, mixed monoclonal cryoglobulinemia, and parotid swelling, all indicators of an extensive lymphoproliferation.3,58,59 This could possibly explain why lymphoid malignancies are more commo”